Search:
   

Friday, June 7, 2024

Equity Corporate Actions Alert #2024 - 271
Information Regarding the Reverse Stock Split and CUSIP Number Change for Kiora Pharmaceuticals, Inc. (KPRX)

Category:

  • Industry Announcement

Markets Impacted:

Contact Information:

Resources

Kiora Pharmaceuticals, Inc. (KPRX) will effect a one-for-nine (1-9) reverse split of its Common stock. The reverse stock split will become effective on Tuesday, June 11, 2024. In conjunction with the reverse split, the CUSIP number will change to 49721T507.

If you would like to register as a market maker in KPRX, contact Nasdaq Trading Operations at +1 212 231 5100.

Email Alert Subscriptions:
Nasdaq offers customers the ability to self select news delivery across various Nasdaq markets. Create and maintain a profile for updating alert preferences and contact information. Visit the enrollment form on the Nasdaq Trader website and sign up today! Please note that if you choose to unsubscribe from an email list, you may no longer receive potentially critical emails from the NASDAQ Stock Market regarding Nasdaq's trading and data products, regulatory issues or marketplace initiatives. To unsubscribe, also click on the enrollment form

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.

View NASDAQTrader.com Mobile